HDAC inhibition potentiates immunotherapy in triple negative breast cancerManuela Terranova-Barberio, Pamela N. Münster, Scott Thomas et al.|Oncotarget|2017Cited by 180
Heterogeneous drug penetrance of veliparib and carboplatin measured in triple negative breast tumorsImke H. Bartelink, Laura van ‘t Veer, Lisa J. Wilmes et al.|Breast Cancer Research|2017Cited by 24
Local delivery of hormonal therapy with silastic tubing for prevention and treatment of breast cancerJeenah Park, Pamela N. Münster, Scott Thomas et al.|Scientific Reports|2018Cited by 8
Additional file 1: of Heterogeneous drug penetrance of veliparib and carboplatin measured in triple negative breast tumorsImke H. Bartelink, Laura van ât Veer, Brendan Prideaux et al.|Figshare|2017Cited by 0
Additional file 1: of Heterogeneous drug penetrance of veliparib and carboplatin measured in triple negative breast tumorsImke H. Bartelink, Laura van ât Veer, Brendan Prideaux et al.|Figshare|2017Cited by 0